{"contentid": 488591, "importid": NaN, "name": "Third-quarter submission now looks likely for Novavax", "introduction": "Slow progress in preparing regulatory submissions will see US vaccines developer Novavax send its COVID-19 vaccine, NVX-CoV2373, for approval in the third quarter at the earliest.", "content": "<p>Slow progress in preparing regulatory submissions will see US vaccines developer Novavax (Nasdaq: NVAX) send its COVID-19 vaccine, NVX-CoV2373, for approval in the third quarter at the earliest.</p>\n<p>In an earnings call discussing first quarter results, chief executive Stanley Erck said the firm was &ldquo;delayed from where we thought we would be at this point.&rdquo;</p>\n<p>He added: &ldquo;Now, we&rsquo;re giving guidance that nearly all of the major challenges have been overcome and we can clearly see the light at the end of the tunnel.&rdquo;</p>\n<p>Markets responded nervously, sending shares down 10% on Monday and a further 10% in after-hours trading.</p>\n<p>The vaccine, which is proven by Phase III data to be safe and highly effective, will be submitted for initial approval in the USA, UK and Europe.</p>\n<h2>More vaccines needed</h2>\n<p>While multiple vaccines against coronavirus have been approved and are in use around the world, there remains a strong need for increased supplies to tackle the outbreak, particularly in lower income countries.</p>\n<p>NVX-CoV2373 is a recombinant protein vaccine, adjuvanted with Novavax&rsquo; proprietary Matrix-M to enhance the immune response.</p>\n<p>Unlike some mRNA-based vaccines, the vaccine does not require special storage conditions and is therefore apt for broad distribution in areas where healthcare infrastructure is not well developed.</p>\n<p>Novavax is aiming to hit a production target of 150 million doses per month in the final quarter of 2021, and currently has about 30 to 40 million doses ready for delivery.</p>\n<p>On a global basis, the number of new coronavirus infections is at an all-time high of over 800,000, although there are some signs that the current peak may be passing.</p>\n<p>Over a billion doses of coronavirus vaccines have been administered, with the USA, UK and other wealthy countries leading the way in terms of vaccine coverage.</p>", "date": "2021-05-11 10:49:00", "meta_title": NaN, "meta_keywords": "vaccine, Novavax, vaccines, quarter, approval, NVX-CoV, Third-quarter, submission, submissions, regulatory, developer, preparing, progress, Slow, send, NVA", "meta_description": "Slow progress in preparing regulatory submissions will see US vaccines developer Novavax send its COVID-19 vaccine, NVX-CoV2373, for approval in the third quart", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-11 10:10:12", "updated": "2021-05-11 10:49:19", "access": NaN, "url": "https://www.thepharmaletter.com/article/third-quarter-submission-now-looks-likely-for-novavax-vaccine", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "novavax-large.png", "image2id": "novavax-small.png", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, Drug Trial, European Medicines Agency, Focus On, Production, Public health, Regulation, Research, US FDA", "geography_tag": "USA", "company_tag": "Novavax", "drug_tag": "NVX-CoV2373", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-11 10:49:00"}